A detailed history of Angeles Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Angeles Investment Advisors, LLC holds 467 shares of VRTX stock, worth $234,644. This represents 0.01% of its overall portfolio holdings.

Number of Shares
467
Previous 467 -0.0%
Holding current value
$234,644
Previous $218,000 0.46%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$392.81 - $485.53 $183,442 - $226,742
467 New
467 $218,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Angeles Investment Advisors, LLC Portfolio

Follow Angeles Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Angeles Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Angeles Investment Advisors, LLC with notifications on news.